卖什么
AI辅助眼部组学检测。
商业模式拆解
买家：谁掌握预算？
未核实NHS hospital eye departments and primary-care eyecare providers (likely trust leadership/clinical leads).
触发点：什么让他们现在购买？
High-volume, high-risk eye disease (e.g. nAMD treatment monitoring) where clinicians need evidence-based decision support to prevent avoidable sight loss.
工作流：什么输入变成什么输出？
Models ingest macula-centred OCT cubes and give clinical decision support for retinal disease and treatment monitoring; oculomics uses retinal imaging to detect systemic disease (cardiovascular, neurodegeneration, dementia) early.
渠道：怎么接触到客户？
未核实Backed and co-launched by Moorfields Eye Hospital, UCL Institute of Ophthalmology and Topcon Healthcare (imaging device maker), implying hospital and device-partner channels.
融资历史与报道
| 融资日期 | 轮次 | 金额 | 投资方 | 来源 |
|---|---|---|---|---|
| 2026-09-24 | 种子轮 | — | — | news.google.com |
档案汇总自公开报道和公司官网。商业模式部分是 MaxBC 对这些材料的解读，不是已确认的事实；未知之处留空，不作猜测。 更新于 2026-10-12.